Unknown

Dataset Information

0

TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation.


ABSTRACT: Dendritic cells (DC) play a central role in immune responses by presenting antigenic peptides to CD4+ T cells through MHCII molecules. Here, we demonstrate a TRIF-GEFH1-RhoB pathway is involved in MHCII surface expression on DC. We show the TRIF (TIR domain-containing adapter inducing IFNbeta)- but not the myeloid differentiation factor 88 (MyD88)-dependent pathway of lipopolysaccharide (LPS)-signaling in DC is crucial for the MHCII surface expression, followed by CD4+ T-cell activation. LPS increased the activity of RhoB, but not of RhoA, Cdc42, or Rac1/2 in a manor dependent on LPS-TRIF- but not LPS-Myd88-signaling. RhoB colocalized with MHCII+ lysosomes in DC. A dominant-negative (DN) form of RhoB (DN-RhoB) or RhoB's RNAi in DC inhibited the LPS-induced MHCII surface expression. Moreover, we found GEFH1 associated with RhoB, and DN-GEFH1 or GEFH1's RNAi suppressed the LPS-mediated RhoB activation and MHCII surface expression. DN-RhoB attenuated the DC's CD4+ T-cell stimulatory activity. Thus, our results provide a molecular mechanism relating how the MHCII surface expression is regulated during the maturation stage of DC. The activation of GEFH1-RhoB through the TRIF-dependent pathway of LPS in DC might be a critical target for controlling the activation of CD4+ T cells.

SUBMITTER: Kamon H 

PROVIDER: S-EPMC1560350 | biostudies-literature | 2006 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation.

Kamon Hokuto H   Kawabe Takaya T   Kitamura Hidemitsu H   Lee Jihye J   Kamimura Daisuke D   Kaisho Tsuneyasu T   Akira Shizuo S   Iwamatsu Akihiro A   Koga Hisashi H   Murakami Masaaki M   Hirano Toshio T  

The EMBO journal 20060817 17


Dendritic cells (DC) play a central role in immune responses by presenting antigenic peptides to CD4+ T cells through MHCII molecules. Here, we demonstrate a TRIF-GEFH1-RhoB pathway is involved in MHCII surface expression on DC. We show the TRIF (TIR domain-containing adapter inducing IFNbeta)- but not the myeloid differentiation factor 88 (MyD88)-dependent pathway of lipopolysaccharide (LPS)-signaling in DC is crucial for the MHCII surface expression, followed by CD4+ T-cell activation. LPS inc  ...[more]

Similar Datasets

| S-EPMC3132756 | biostudies-literature
| S-EPMC4235642 | biostudies-literature
| S-EPMC1765444 | biostudies-literature
| S-EPMC9258186 | biostudies-literature
| S-EPMC4042642 | biostudies-literature
| S-EPMC4297742 | biostudies-literature
| S-EPMC5716026 | biostudies-literature
| S-EPMC4483068 | biostudies-literature
| S-EPMC3702379 | biostudies-literature
| S-EPMC6608971 | biostudies-literature